Hofseth Biocare ASA (HBC) — Cash Flow Reinvestment Rate
Hofseth Biocare ASA (HBC) has a Cash Flow Reinvestment Rate of 2.87x as of December 2024, reinvesting Nkr2.44 Million (capex Nkr1.22 Million plus investments Nkr-1.22 Million) from operating cash flow of Nkr851.00K. Check Hofseth Biocare ASA earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hofseth Biocare ASA Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Hofseth Biocare ASA across 2 annual periods. Explore Hofseth Biocare ASA (HBC) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hofseth Biocare ASA (2015–2023)
Year-by-year capital reinvestment analysis for Hofseth Biocare ASA. For live market cap and broader valuation context, see Hofseth Biocare ASA market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 9.51x | Nkr26.25 Million | Nkr2.76 Million | Nkr8.19 Million | ▲ +512.0% |
| 2015 | 1.55x | Nkr12.37 Million | Nkr7.97 Million | Nkr11.84 Million | — |